Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026)
Repligen's (RGEN) quarterly Other Non-Current Liabilities came in at $17.1 million in Q2 2026, up 1.31% year-over-year from $16.9 million in Q2 2025, and up 2.0% quarter-over-quarter from $16.8 million in Q1 2026.
Analysis
Repligen (RGEN) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Other Non-Current Liabilities for 16 consecutive years, with $17.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 1.31% year-over-year to $17.1 million in Q2 2026; TTM through Jun 2026 was $17.1 million, a 1.31% increase from a year earlier, with the FY2025 full-year figure at $15.6 million, down 57.72% from the prior year.
- Other Non-Current Liabilities was $17.1 million for Q2 2026 at Repligen, up from $16.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $69.1 million in Q3 2022 and troughed at $11.3 million in Q1 2024.
- A 5-year average of $29.7 million and a median of $17.1 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities jumped 4515.7% in 2022 and slumped 80.1% in 2023, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $51.6 million in 2022, then tumbled by 72.71% to $14.1 million in 2023, then jumped by 161.46% to $36.8 million in 2024, then sank by 57.72% to $15.6 million in 2025, then increased by 9.87% to $17.1 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $17.1 million (Q2 2026), $16.8 million (Q1 2026), and $15.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.09 Mn |
| Mar 31, 2026 | 16.76 Mn |
| Dec 31, 2025 | 15.56 Mn |
| Sep 30, 2025 | 17.32 Mn |
| Jun 30, 2025 | 16.87 Mn |
| Mar 31, 2025 | 17.08 Mn |
| Dec 31, 2024 | 36.79 Mn |
| Sep 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 11.48 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 14.07 Mn |
| Sep 30, 2023 | 13.76 Mn |
| Jun 30, 2023 | 44.28 Mn |
| Mar 31, 2023 | 38.91 Mn |
| Dec 31, 2022 | 51.56 Mn |
| Sep 30, 2022 | 69.14 Mn |
| Jun 30, 2022 | 67.90 Mn |
| Mar 31, 2022 | 64.04 Mn |
| Dec 31, 2021 | 94.24 Mn |
| Sep 30, 2021 | 79.96 Mn |